Company Overview and News

26
Leach natgas pipe, after West Virginia blast, to resume operations early July

2018-06-19 reuters
June 19 (Reuters) - TransCanada Corp’s Columbia Gas Transmission (TCO) unit has estimated that the section of the Leach Xpress natural gas pipeline, damaged in a blast on June 7 in Marshall County, West Virginia, will resume operations early in July.
ENBBF ETP.PRC TRP RRL ENB RRS TEP RGRLF RRC ENB EQM ETP RGRYY EBBNF

9
24 High Yield 'Safer' Dividend Energy Equities For June

2018-06-17 seekingalpha
24 of 86 Energy Sector top yield stocks were deemed "safer" for dividends because they showed positive annual-returns, and free cash-flow yields greater than their dividend yields 6/14/18.
HEP EQM CAPL SHLX GLOP.PRA GLOP.PRB GLOP SUN GPP VLP TEP SNMP

27
TransCanada Fixes Part of Leach Xpress Natgas Pipe after W.Va. Blast

2018-06-15 rigzone
June 15 (Reuters) - TransCanada Corp's Columbia Gas Transmission (TCO) unit said it fixed a section of the Leach Xpress natural gas pipeline downstream of a pipe blast in West Virginia last week.
ENBBF ETP.PRC TRP RRL ENB RRS TEP RGRLF RRC ENB EQM ETP RGRYY TRI EBBNF

2
TEP / Tallgrass Energy Partners, LP 8-K (Prospectus)

2018-06-14 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TEP

1
TEP / Tallgrass Energy Partners, LP 8-K (Current Report)

2018-06-14 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TEP

27
TransCanada Working On Leach Xpress Natgas Pipe After W. Va. Blast

2018-06-13 rigzone
June 13 (Reuters) - TransCanada Corp's Columbia Gas Transmission (TCO) unit said it was working on a section of the Leach Xpress natural gas pipeline downstream of a pipe blast in West Virginia last week.
ENBBF ETP.PRC TRP RRL ENB RRS TEP RGRLF RRC ENB EQM ETP RGRYY TRI EBBNF

26
TransCanada working on Leach Xpress natgas pipe after W.Va. blast

2018-06-13 reuters
June 13 (Reuters) - TransCanada Corp’s Columbia Gas Transmission (TCO) unit said it was working on a section of the Leach Xpress natural gas pipeline downstream of a pipe blast in West Virginia last week.
ENBBF ETP.PRC TRP RRL ENB RRS TEP RGRLF RRC ENB EQM ETP RGRYY EBBNF

17
MLP Insights: Q2 2018

2018-06-10 seekingalpha
2018 has not stopped the wild ride for MLP investors that began in 2014. The initial euphoria of tax reform earlier in the year abated as the broad equity markets became more volatile. In mid-March as the Federal Energy Regulatory Commission (FERC) rulingdisallowing a previously accepted MLP income tax allowance saw fatigued investors exit the MLP market. While MLPs have recovered by more than 14% since the nadir in late-March,1 a new elephant has entered the room: uncertainty around the future of the MLP structure.
APLP SNSR AND LIT BFIT KMI.WS GXG SIL KRMA GXF CHII TEP SEP ACTX CHIE WPZ GOEX KMI.PRA KMI FINX CHIX EEP KMR CVB SRET BOTZ CATH GURX GURI ALUM MILN CJHIQ URA TCP LNGR COPX QQQC GURU KMRFZ

27
No Natgas Flows Through W. Va. Leach Xpress, Producers Use Other Pipes

2018-06-08 rigzone
June 8 (Reuters) - TransCanada Corp said on Friday it cannot move natural gas until further notice through the section of its Leach Xpress pipeline in West Virginia that ruptured early Thursday until, prompting customers to seek other pipelines to ship their gas.
ENBBF ETP.PRC TRP RRL ENB RRS TEP RGRLF RRC ENB EQM ETP RGRYY TRI EBBNF

26
No natgas flows through W. Va. Leach Xpress, producers use other pipes

2018-06-08 reuters
(Reuters) - TransCanada Corp said on Friday it cannot move natural gas until further notice through the section of its Leach Xpress pipeline in West Virginia that ruptured early Thursday until, prompting customers to seek other pipelines to ship their gas.
ENBBF ETP.PRC TRP RRL ENB RRS TEP RGRLF RRC ENB EQM ETP RGRYY EBBNF

2
A 9% Yield, 11 Straight Hikes, No K-1, Big Quarterly Growth Again, IDR Swap In June

2018-06-07 seekingalpha
The GP yields 8.96%, and management raised quarterly payout by 37% as part of upcoming merger.
MTSI TEP TEGP

3
Kayne Anderson Energy Development Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at May 31, 2018

2018-06-05 globenewswire
HOUSTON, Texas, June 04, 2018 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Development Company (the “Company”) (NYSE:KED) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of May 31, 2018.
WMB KED TEP TEGP

2
MLP Rating Updates for the Week Ending May 18

2018-05-22 marketrealist
Legacy Reserves (LGCY), an upstream MLP involved in crude oil, natural gas, and NGLs (natural gas liquids) production, was upgraded by UBS in the week ending May 18. UBS upgraded Legacy Reserves to “neutral,” which is equivalent to a “hold” from “sell.” UBS increased Legacy Reserves’ target price to $8 from $1.5. Currently, only one analyst has coverage on Legacy Reserves. The partnership is trading above its target price.
LGCYP TCP LGCYO GMLP HMLP GLOP.PRA GLOP.PRB LGCY GLOP HMLP.PRA TEP

2
TEP / Tallgrass Energy Partners, LP DEFM14A

2018-05-18 sec.gov
DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TEP

43
Master Limited Partnership Simplifications On The Rise

2018-05-18 seekingalpha
The three only mark an acceleration of the trend of MLP "roll-ups," however. Many others have been announced in 2018.
ARLP LGCYP APLP LGCYO CQP EBGUF RMP AROC ENB TEP TEGP SEP NSH EQM WPZ WMB EQGP EEP LNG BWP L ENB ENF LGCY

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

12h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

13h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to TEP / Tallgrass Energy Partners, LP on message board site Silicon Investor.

Ultratech Stepper A Journey Of 1,000 Miles Begins With A Single Step - Help!
Preparing For The Next Surge - In 4 Steps LocatePlus.com (LPLHA)
Argue u0026 Fight about it here! Just step outside - to here! Steppe Gold (SPE:V)
12-STEP XOMA-HOLIC RECOVERY THREAD eDispatch.com EWD.V (formerly Instep Mobile)
Trans Orient Petroleum (TEPUF) STW.V STEPTWO SOFTWARE ON THE VANCOUVER EXCHANGE??
CUSIP: 874697105